Press "Enter" to skip to content

MedicallyPrime.Com

NMO Gets a New Drug

Subcutaneous satralizumab (Enspryng) won FDA approval to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive, Genentech announced late Friday.…